We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Virtual sessions of Alcoholics Anonymous, which have become common during the pandemic, are likely to become a permanent part of recovery, according to participants and addiction treatment providers.
This week a federal bankruptcy judge authorized a settlement valued at $8.3 billion between OxyContin maker Purdue Pharma and the Department of Justice, NPR reports.
Supervising drug consumption at a needle exchange program in Boston would save three to four lives a year, and more than $4 million, according to a new report.
A recent Gallup poll and the passage of state marijuana legalization measures indicate that bipartisan support for legalization is growing, AP reports.
After New York State implemented an excise tax on many opioids in July 2019, some patients have had difficulty filling opioid prescriptions, Kaiser Health News reports.
A large drug company and three major drug distributors have proposed a $26 billion deal with state and local governments that sued them for their role in the opioid crisis. If the deal is finalized, the companies would be shielded from future opioid-related lawsuits from these governments, The New York Times reports.
A new study finds “diseases of despair,” including alcohol and drug misuse and suicidal thoughts and behaviors, rose dramatically in the United States between 2009 and 2018.
A group of Democratic senators is urging the Justice Department to drop its efforts to convert OxyContin maker Purdue Pharma into a public asset, The Wall Street Journal reports.
Public health messages are needed to educate people about how to manage stress and anxiety without using alcohol during the pandemic, according to addiction experts at McLean Hospital.
A new small study finds the hallucinogenic drug psilocybin was more effective than standard antidepressants in treating major depressive disorder, NPR reports.
Walmart has filed a lawsuit against the U.S. government, asking a court to declare the company and its pharmacists were not responsible for improperly distributing opioid prescriptions.
A measure that would decriminalize personal use of drugs including heroin, cocaine and methamphetamine will be on the ballot in Oregon on November 3, The New York Times reports.
The COVID-19 pandemic may be making it harder for pregnant women to receive treatment for opioid addiction, according to the author of a new report on opioid use in pregnancy.
Purdue Pharma, maker of the prescription opioid OxyContin, agreed on Wednesday to plead guilty to criminal charges over the company’s role in the nation’s opioid crisis, The New York Times reports. The company faces $8.3 billion in penalties.
Drug overdose deaths increased 10% during the first three months of this year, preliminary data released by the Centers for Disease Control and Prevention indicates.
A new study finds almost one-third of high school seniors who reported misusing prescription opioids but did not receive a prescription for the drugs ended up using heroin by age 35.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
